Moderna opens $110M manufacturing site for its mRNA program

Moderna opens $110M manufacturing site for its mRNA program

Source: 
Fierce Pharma
snippet: 

Moderna Therapeutics, which is pushing a pipeline of mRNA candidates into phase 2 trials, now has a manufacturing plant ready to advance its highly anticipated program.